{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-010228","form_type":"8-K","ticker":"QSI","cik":"0001816431","company_name":"Quantum-Si Inc","filed_at":"2023-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.725832+00:00","generated_at":"2026-06-18T12:02:09.145112+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Quantum-Si reports FY2022 net loss of $132.4M; begins Platinum shipments, expects Q1 2023 revenue","bullets":["Q4 2022 net loss $33.1M vs $29.4M in Q4 2021; FY2022 net loss $132.4M vs $95.0M in FY2021.","Cash and investments $351.3M as of Dec 31, 2022; company projects cash runway into 2026.","Launched Platinum protein sequencer in Dec 2022; began shipments early Q1 2023; expects first revenue in Q1 2023.","Non-GAAP operating expenses expected approximately flat in 2023 vs 2022; restructuring to reduce costs.","Hired Grace Johnston as Chief Commercial Officer; partnered with Aviva Systems Biology and Biovista."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-010228","json":"https://secwatch.observer/filing/0001140361-23-010228.json","markdown":"https://secwatch.observer/filing/0001140361-23-010228.md","text":"https://secwatch.observer/filing/0001140361-23-010228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123010228/0001140361-23-010228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123010228/brhc10049258_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T12:02:09.145112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fccf4e00793e2249f8cf0334a3cc7a896cb17a2b","claim":"Quantum-Si Inc reported the fourth quarter and full year ended December 31, 2022 results: net income Net loss was $33.1 million in the fourth quarter of 2022, compared to a net loss of $29.4 million in the fourth quarter.","evidence_excerpt":"On March 6, 2023, Quantum-Si Incorporated (the “Company”) issued a press release announcing its results for the fourth quarter and full year ended December 31, 2022 and providing a business update.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123010228/0001140361-23-010228-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2022"},{"label":"Net income","value":"Net loss was $33.1 million in the fourth quarter of 2022, compared to a net loss of $29.4 million in the fourth quarter"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}